Projects per year
Personal profile
Personal profile
Dr. Ganguly is a board-certified hematologist specializing in the clinical care and research of hematological malignancies, cellular therapeutics, and bone marrow transplantation. Dr. Ganguly was a A. Drue Jennings endowed professor of medical oncology at the University of Kansas Cancer Center in Westwood, Kansas where he was also the Deputy Director of the Division of Hematological Malignancies and Cellular Therapeutics, the Associate Director of Blood and Marrow Transplantation Program, and the Director of Lymphoma and Myeloma Program.
Dr. Ganguly received his undergraduate degree from Calcutta Medical College and his medical degree from the Department of Internal Medicine, Post Graduate, Institute of Medical Education and Research in India. Additionally, he completed his residency in internal medicine and fellowship in hematology at Baylor College of Medicine and concluded another fellowship in bone marrow transplantation at Baylor College of Medicine, Center for Cell and Gene Therapy.
External positions
Professor of Clinical Medicine, Weill Cornell Medical College
May 1 2022 → …
Research Area Keywords
- Cancer
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Shah, S.
3/30/23 → …
Project: Clinical Trial
-
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Rice, L.
9/21/22 → …
Project: Clinical Trial
-
Daratumab to Enhance therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
4/30/19 → 4/29/29
Project: Non Profit
-
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Murthy, H. S., Zhang, M. J., Chen, K., Ahmed, S., Deotare, U., Ganguly, S., Kansagra, A., Michelis, F. V., Nishihori, T., Patnaik, M., Abid, M. B., Aljurf, M., Arai, Y., Bacher, U., Badar, T., Badawy, S. M., Ballen, K., Battiwalla, M., Beitinjaneh, A., Bejanyan, N., & 49 others , 2023, In: Blood Advances. 7, 22, p. 7007-7016 10 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
Tamari, R., McLornan, D. P., Ahn, K. W., Estrada-Merly, N., Hernández-Boluda, J. C., Giralt, S., Palmer, J., Gale, R. P., DeFilipp, Z., Marks, D. I., van der Poel, M., Verdonck, L. F., Battiwalla, M., Diaz, M. A., Gupta, V., Ali, H., Litzow, M. R., Lazarus, H. M., Gergis, U., Bashey, A., & 31 others , Aug 8 2023, In: Blood Advances. 7, 15, p. 3993-4002 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Murthy, G. S. G., Kim, S., Estrada-Merly, N., Abid, M. B., Aljurf, M., Assal, A., Badar, T., Badawy, S. M., Ballen, K., Beitinjaneh, A., Cerny, J., Chhabra, S., DeFilipp, Z., Dholaria, B., Perez, M. A. D., Farhan, S., Freytes, C. O., Gale, R. P., Ganguly, S., Gupta, V., & 29 others , Jul 1 2023, In: Haematologica. 108, 7, p. 1900-1908 9 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia
Shao, J., Shah, S., Ganguly, S., Zu, Y., He, C. & Li, Z., Dec 2023, In: Clinical Epigenetics. 15, 1, 134.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine
Shao, J., Shah, S., Ganguly, S., Zu, Y., He, C. & Li, Z., May 28 2023, In: Genes. 14, 6, 1180.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations